Lead sponsor
Centre Hospitalier Universitaire Dijon
5 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 1, 2026.
5
Trials led
1
Active
323
Total enrollment
2
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 3
1
Phase 4
2
Not applicable
2
Trials by status
Recruiting
1
Completed
2
Terminated
2
Trials led
TrialKey I/E criterionPhaseStatusEnrollment
Impact of Liraglutide on Sensory Perception, Sensory Specific Satiety, Liking and Wanting in Type 2 Diabetic PatientsBMI ≥25not applicableCompleted30